Showing results (1-10 of 473) with videos related to
Sort By:
Pageof 48
Cancer Journal (Sudbury, Mass.)|August 16, 2021
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand NowThomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, et al.Hematology. American Society of Hematology. Education Program|December 13, 2012
A look into the future: can minimal residual disease guide therapy and predict prognosis in chronic lymphocytic leukemia?Paolo GhiaHematological Oncology|September 7, 2018
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paperAntonio Cuneo, Giovanni Barosi, Romano Danesi, et al.Leukemia|April 28, 2018
Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatmentsPaolo Ghia, Andy RawstronImmunology Letters|October 8, 2013
Reprogramming cell death: BCL2 family inhibition in hematological malignanciesLydia Scarfò, Paolo GhiaFrontiers in Oncology|January 4, 2021
Modeling the Leukemia Microenviroment <i>In Vitro</i>Cristina Scielzo, Paolo GhiaSeminars in Oncology|April 5, 2016
What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challengesLydia Scarfò, Paolo GhiaSeminars in Oncology|April 18, 2006
The origin of B-cell chronic lymphocytic leukemiaPaolo Ghia, Federico Caligaris-CappioHematology/Oncology Clinics of North America|August 25, 2004
The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative modelFederico Caligaris-Cappio, Paolo GhiaPageof 48